Advances in antibody engineering for rheumatic diseases

Advances in antibody engineering for rheumatic diseasesAdvances in antibody engineering for rheumatic diseases, Published online: 27 February 2019; doi:10.1038/s41584-019-0188-8Antibody therapeutics are a mainstay of treating patients with rheumatic diseases but are mostly basic monoclonal structures. What can the history of and modern developments in antibody technology tell us about the next generation of antibody-based therapeutics?

Source: Nature Reviews Rheumatology - February 27, 2019 Category: Rheumatology Authors: Anja S. Schmid Dario Neri Source Type: research